These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2830403)

  • 1. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.
    Manganiello VC
    J Mol Cell Cardiol; 1987 Oct; 19(10):1037-40. PubMed ID: 2830403
    [No Abstract]   [Full Text] [Related]  

  • 2. cGMP-inhibited phosphodiesterases (PDE3 gene family).
    Degerman E; Belfrage P; Manganiello VC
    Biochem Soc Trans; 1996 Nov; 24(4):1010-4. PubMed ID: 8968502
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms involved in the antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase.
    Manganiello VC; Smith CJ; Degerman E; Vasta V; Tornqvist H; Belfrage P
    Adv Exp Med Biol; 1991; 293():239-48. PubMed ID: 1662861
    [No Abstract]   [Full Text] [Related]  

  • 4. Type III cyclic nucleotide phosphodiesterases and insulin action.
    Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
    Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of multiple cAMP-specific phosphodiesterase variants.
    Bushnik T; Conti M
    Biochem Soc Trans; 1996 Nov; 24(4):1014-9. PubMed ID: 8968503
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes.
    Maurice DH
    Proc West Pharmacol Soc; 2003; 46():32-6. PubMed ID: 14699879
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotides and lipolysis.
    Pohl SL
    Int J Obes; 1981; 5(6):627-33. PubMed ID: 6274817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors.
    Pang DC
    Adv Second Messenger Phosphoprotein Res; 1992; 25():307-20. PubMed ID: 1313264
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin.
    Manganiello VC; Degerman E; Smith CJ; Vasta V; Tornqvist H; Belfrage P
    Adv Second Messenger Phosphoprotein Res; 1992; 25():147-64. PubMed ID: 1313257
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic-3',5'-nucleotide phosphodiesterases in the cyclic adenosine monophosphate (cAMP)-mediated actions of vasopressin.
    Dousa TP
    Semin Nephrol; 1994 Jul; 14(4):333-40. PubMed ID: 7938948
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases.
    Sette C; Vicini E; Conti M
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):75-9. PubMed ID: 8056162
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V; Degerman E; Elks M
    Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility.
    Weishaar RE; Kobylarz-Singer DC; Quade MM; Steffen RP; Kaplan HR
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):513-27. PubMed ID: 2831259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.